Ledger.Open graph →
SEC Form D · filed December 5, 2014

Eleven Biotherapeutics, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Daniel S. Lynch · Cambridge, MADirectorAbbie C. Celniker, Ph.D · Cambridge, MAExec · DirectorJane V. Henderson · Cambridge, MADirectorWendy L. Dixon · Cambridge, MADirectorPaul G. Chaney · Cambridge, MADirectorDavid A. Berry · Cambridge, MAExec · DirectorEric S. Furfine · Cambridge, MAExecCary G. Pfeffer · Cambridge, MADirectorRudolphe S. Otter · PASADENA, CAExec · DirectorGregory D. Perry · Cambridge, MAExecKaren L. Turbridy · Cambridge, MAExecSteve Adler · Santa Monica, CADirectorGavin L. James · PASADENA, CAExec · DirectorMichael B. Zelouf · PASADENA, CAExec · DirectorDavid E. Flynn · Draper, UTDirectorSteven E. Brox · Draper, UTDirectorLohra L. Miller · Draper, UTDirectorJane V. Henderson · Cambridge, MADirectorGregory D. Perry · Cambridge, MAExecEric S. Furfine · Cambridge, MAExecKaren L. Turbridy · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗